Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Zenas BioPharma, Inc. Common Stock Share Price

ZBIO

NSQ

$26.68

-$0.09

(-0.34%)

Industry: Biotechnology Sector: Health Care

Zenas BioPharma, Inc. Common Stock Analyst Forecast

Overview Returns Financials Ratios News FAQs

Zenas BioPharma, Inc. Common Stock Share Price Chart

Zenas BioPharma, Inc. Common Stock Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$1.44B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

2.6086

Volume

This is the total number of shares traded during the most recent trading day.

423.64K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$6.11 L

$44.6 H

$26.68

About Zenas BioPharma, Inc. Common Stock, Common Stock

Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc"RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is headquartered in Waltham, Massachusetts. more

Industry: BiotechnologySector: Health Care

Zenas BioPharma, Inc. Common Stock Stock Returns

Time Frame	ZBIO	Sector	S&P500
1-Week Return	14.65%	0.72%	-1.31%
1-Month Return	27.78%	1.27%	0.78%
3-Month Return	-26.32%	3.13%	3.46%
6-Month Return	54.4%	15.81%	6.19%
1-Year Return	301.2%	8.89%	11.68%
3-Year Return	47%	20.79%	71.21%

Time Frame	ZBIO	Sector	S&P500
1-Week Return	124,619.13%	45.37%	-49.72%
1-Month Return	1,873.78%	16.60%	9.91%
3-Month Return	-71.02%	13.31%	14.79%
6-Month Return	141.29%	34.67%	12.95%
1-Year Return	301.20%	8.89%	11.68%
3-Year Return	13.70%	6.50%	19.63%

Zenas BioPharma, Inc. Common Stock Financials

	Dec '22	Dec '23	Dec '24
Total Revenue	-	50.00M	5.00M	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":10,"profit":true}]
Cost of Revenue	61.69M	113.00K	139.14M	[{"date":"2022-12-31","value":44.34,"profit":true},{"date":"2023-12-31","value":0.08,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	(61.69M)	50.00M	(134.14M)	[{"date":"2022-12-31","value":-123.38,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-268.28,"profit":false}]
Gross Margin	-	100.00%	(2682.78%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-2682.78,"profit":false}]

Operating Expenses	14.51M	87.15M	29.75M	[{"date":"2022-12-31","value":16.65,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":34.14,"profit":true}]
Operating Income	(76.20M)	(37.15M)	(163.89M)	[{"date":"2022-12-31","value":-7619900000,"profit":false},{"date":"2023-12-31","value":-3714700000,"profit":false},{"date":"2024-12-31","value":-16388800000,"profit":false}]
Total Non-Operating Income/Expense	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income	(119.28M)	(36.82M)	(156.56M)	[{"date":"2022-12-31","value":-11928200000,"profit":false},{"date":"2023-12-31","value":-3682300000,"profit":false},{"date":"2024-12-31","value":-15655900000,"profit":false}]
Income Taxes	-	301.00K	429.00K	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":70.16,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	(119.28M)	(37.12M)	(156.99M)	[{"date":"2022-12-31","value":-11928200000,"profit":false},{"date":"2023-12-31","value":-3712400000,"profit":false},{"date":"2024-12-31","value":-15698800000,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(119.28M)	(37.12M)	(156.99M)	[{"date":"2022-12-31","value":-11928200000,"profit":false},{"date":"2023-12-31","value":-3712400000,"profit":false},{"date":"2024-12-31","value":-15698800000,"profit":false}]

EPS (Diluted)	-	-	(9.07)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-907,"profit":false}]

	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	(90.00%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Cost of Revenue	-	(99.82%)	123031.86%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-0.08,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	-	(181.05%)	(368.28%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Gross Margin	-	-	(2782.78%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]

Operating Expenses	-	500.60%	(65.86%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-13.16,"profit":false}]
Operating Income	-	(51.25%)	341.19%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-15.02,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income	-	(69.13%)	325.17%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-21.26,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	-	-	42.52%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(68.88%)	322.87%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-21.33,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	(68.88%)	322.87%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-21.33,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	5.00M	10.00M	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":50,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	33.53M	33.00K	23.00K	43.03M	5.00M	[{"date":"2024-09-30","value":77.93,"profit":true},{"date":"2024-12-31","value":0.08,"profit":true},{"date":"2025-03-31","value":0.05,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":11.62,"profit":true}]
Gross Profit	(33.53M)	5.00M	10.00M	(43.03M)	(5.00M)	[{"date":"2024-09-30","value":-335.3,"profit":false},{"date":"2024-12-31","value":50,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-430.27,"profit":false},{"date":"2025-09-30","value":-50,"profit":false}]
Gross Margin	-	100.00%	100.00%	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	7.45M	60.62M	47.33M	12.14M	47.58M	[{"date":"2024-09-30","value":12.3,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":78.07,"profit":true},{"date":"2025-06-30","value":20.02,"profit":true},{"date":"2025-09-30","value":78.49,"profit":true}]
Operating Income	(40.98M)	(55.62M)	(37.33M)	(55.16M)	(52.58M)	[{"date":"2024-09-30","value":-4098400000,"profit":false},{"date":"2024-12-31","value":-5562300000,"profit":false},{"date":"2025-03-31","value":-3733000000,"profit":false},{"date":"2025-06-30","value":-5516300000,"profit":false},{"date":"2025-09-30","value":-5258000000,"profit":false}]
Total Non-Operating Income/Expense	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Pre-Tax Income	(38.61M)	(52.17M)	(33.78M)	(52.20M)	(51.50M)	[{"date":"2024-09-30","value":-3860600000,"profit":false},{"date":"2024-12-31","value":-5217500000,"profit":false},{"date":"2025-03-31","value":-3377800000,"profit":false},{"date":"2025-06-30","value":-5220300000,"profit":false},{"date":"2025-09-30","value":-5149900000,"profit":false}]
Income Taxes	-	429.00K	(205.00K)	20.00K	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-47.79,"profit":false},{"date":"2025-06-30","value":4.66,"profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	(38.61M)	(52.60M)	(33.57M)	(52.22M)	(51.50M)	[{"date":"2024-09-30","value":-3860600000,"profit":false},{"date":"2024-12-31","value":-5260400000,"profit":false},{"date":"2025-03-31","value":-3357300000,"profit":false},{"date":"2025-06-30","value":-5222300000,"profit":false},{"date":"2025-09-30","value":-5149900000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(38.61M)	(52.60M)	(33.57M)	(52.22M)	(51.50M)	[{"date":"2024-09-30","value":-3860600000,"profit":false},{"date":"2024-12-31","value":-5260400000,"profit":false},{"date":"2025-03-31","value":-3357300000,"profit":false},{"date":"2025-06-30","value":-5222300000,"profit":false},{"date":"2025-09-30","value":-5149900000,"profit":false}]

EPS (Diluted)	(5.02)	(1.26)	(0.80)	(1.25)	(1.22)	[{"date":"2024-09-30","value":-502,"profit":false},{"date":"2024-12-31","value":-126,"profit":false},{"date":"2025-03-31","value":-80,"profit":false},{"date":"2025-06-30","value":-125,"profit":false},{"date":"2025-09-30","value":-122,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	-	100.00%	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	-	(99.90%)	(30.30%)	186973.91%	(88.38%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-0.05,"profit":false},{"date":"2025-03-31","value":-0.02,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-0.05,"profit":false}]
Gross Profit	-	(114.91%)	100.00%	(530.27%)	(88.38%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-114.91,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-530.27,"profit":false},{"date":"2025-09-30","value":-88.38,"profit":false}]
Gross Margin	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	-	713.29%	(21.93%)	(74.36%)	292.06%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-3.07,"profit":false},{"date":"2025-06-30","value":-10.42,"profit":false},{"date":"2025-09-30","value":40.94,"profit":true}]
Operating Income	-	35.72%	(32.89%)	47.77%	(4.68%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":74.77,"profit":true},{"date":"2025-03-31","value":-68.84,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-9.8,"profit":false}]
Total Non-Operating Income/Expense	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Pre-Tax Income	-	35.15%	(35.26%)	54.55%	(1.35%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":64.43,"profit":true},{"date":"2025-03-31","value":-64.64,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-2.47,"profit":false}]
Income Taxes	-	-	(147.79%)	(109.76%)	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	36.26%	(36.18%)	55.55%	(1.39%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":65.27,"profit":true},{"date":"2025-03-31","value":-65.13,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-2.5,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	36.26%	(36.18%)	55.55%	(1.39%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":65.27,"profit":true},{"date":"2025-03-31","value":-65.13,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-2.5,"profit":false}]

EPS (Diluted)	-	(74.90%)	(36.51%)	56.25%	(2.40%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-133.16,"profit":false},{"date":"2025-03-31","value":-64.9,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-4.27,"profit":false}]

	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	68.44M	59.80M	355.92M	[{"date":"2022-12-31","value":19.23,"profit":true},{"date":"2023-12-31","value":16.8,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	6.13M	8.38M	14.04M	[{"date":"2022-12-31","value":43.68,"profit":true},{"date":"2023-12-31","value":59.64,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	74.58M	68.18M	369.97M	[{"date":"2022-12-31","value":20.16,"profit":true},{"date":"2023-12-31","value":18.43,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	25.97M	23.26M	57.29M	[{"date":"2022-12-31","value":45.32,"profit":true},{"date":"2023-12-31","value":40.6,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	240.90M	270.64M	218.00K	[{"date":"2022-12-31","value":89.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":0.08,"profit":true}]
Total Liabilities	266.87M	293.90M	57.51M	[{"date":"2022-12-31","value":90.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":19.57,"profit":true}]

Total Shareholders' equity
Common Stock	1.00K	1.00K	4.00K	[{"date":"2022-12-31","value":25,"profit":true},{"date":"2023-12-31","value":25,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(193.28M)	(230.40M)	(387.39M)	[{"date":"2022-12-31","value":-19327900000,"profit":false},{"date":"2023-12-31","value":-23040300000,"profit":false},{"date":"2024-12-31","value":-38739100000,"profit":false}]
Other Stockholders' Equity	1.03M	4.64M	699.65M	[{"date":"2022-12-31","value":0.15,"profit":true},{"date":"2023-12-31","value":0.66,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	(192.29M)	(225.72M)	312.46M	[{"date":"2022-12-31","value":-61.54,"profit":false},{"date":"2023-12-31","value":-72.24,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	74.58M	68.18M	369.97M	[{"date":"2022-12-31","value":20.16,"profit":true},{"date":"2023-12-31","value":18.43,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	-	(12.62%)	495.15%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-2.55,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	-	36.53%	67.68%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":53.97,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	-	(8.58%)	442.63%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-1.94,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	(10.43%)	146.33%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-7.13,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	-	12.35%	(99.92%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-809.22,"profit":false}]
Total Liabilities	-	10.13%	(80.43%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-793.92,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	300.00%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	-	19.21%	68.14%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":28.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	349.23%	14962.45%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":2.33,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	17.39%	(238.43%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-1371.2,"profit":false}]

Total Liabilities & Shareholders Equity	-	(8.58%)	442.63%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-1.94,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	393.78M	355.92M	317.81M	278.60M	296.64M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":90.39,"profit":true},{"date":"2025-03-31","value":80.71,"profit":true},{"date":"2025-06-30","value":70.75,"profit":true},{"date":"2025-09-30","value":75.33,"profit":true}]
Non-current Assets	9.65M	14.04M	15.96M	14.48M	25.38M	[{"date":"2024-09-30","value":38.04,"profit":true},{"date":"2024-12-31","value":55.35,"profit":true},{"date":"2025-03-31","value":62.89,"profit":true},{"date":"2025-06-30","value":57.07,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	403.43M	369.97M	333.77M	293.08M	322.02M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":91.71,"profit":true},{"date":"2025-03-31","value":82.73,"profit":true},{"date":"2025-06-30","value":72.65,"profit":true},{"date":"2025-09-30","value":79.82,"profit":true}]

Total Liabilities
Current Liabilities	44.00M	57.29M	49.13M	53.24M	52.42M	[{"date":"2024-09-30","value":76.79,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":85.76,"profit":true},{"date":"2025-06-30","value":92.93,"profit":true},{"date":"2025-09-30","value":91.5,"profit":true}]
Non-current Liabilities	-	218.00K	317.00K	215.00K	73.17M	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":0.3,"profit":true},{"date":"2025-03-31","value":0.43,"profit":true},{"date":"2025-06-30","value":0.29,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Liabilities	44.00M	57.51M	49.45M	53.46M	125.59M	[{"date":"2024-09-30","value":35.03,"profit":true},{"date":"2024-12-31","value":45.79,"profit":true},{"date":"2025-03-31","value":39.37,"profit":true},{"date":"2025-06-30","value":42.57,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	4.00K	4.00K	4.00K	4.00K	4.00K	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(334.79M)	(387.39M)	(420.96M)	(473.19M)	(524.69M)	[{"date":"2024-09-30","value":-33478600000,"profit":false},{"date":"2024-12-31","value":-38739100000,"profit":false},{"date":"2025-03-31","value":-42096400000,"profit":false},{"date":"2025-06-30","value":-47318700000,"profit":false},{"date":"2025-09-30","value":-52468600000,"profit":false}]
Other Stockholders' Equity	694.16M	699.65M	705.14M	712.90M	721.18M	[{"date":"2024-09-30","value":96.25,"profit":true},{"date":"2024-12-31","value":97.01,"profit":true},{"date":"2025-03-31","value":97.78,"profit":true},{"date":"2025-06-30","value":98.85,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	359.44M	312.46M	284.32M	239.63M	196.43M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":86.93,"profit":true},{"date":"2025-03-31","value":79.1,"profit":true},{"date":"2025-06-30","value":66.67,"profit":true},{"date":"2025-09-30","value":54.65,"profit":true}]

Total Liabilities & Shareholders Equity	403.43M	369.97M	333.77M	293.08M	322.02M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":91.71,"profit":true},{"date":"2025-03-31","value":82.73,"profit":true},{"date":"2025-06-30","value":72.65,"profit":true},{"date":"2025-09-30","value":79.82,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(9.61%)	(10.71%)	(12.34%)	6.47%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-148.47,"profit":false},{"date":"2025-03-31","value":-165.4,"profit":false},{"date":"2025-06-30","value":-190.52,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Assets	-	45.48%	13.63%	(9.25%)	75.22%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":60.46,"profit":true},{"date":"2025-03-31","value":18.12,"profit":true},{"date":"2025-06-30","value":-12.3,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	-	(8.29%)	(9.79%)	(12.19%)	9.87%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-84.02,"profit":false},{"date":"2025-03-31","value":-99.12,"profit":false},{"date":"2025-06-30","value":-123.47,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	30.22%	(14.24%)	8.37%	(1.55%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-47.13,"profit":false},{"date":"2025-06-30","value":27.7,"profit":true},{"date":"2025-09-30","value":-5.12,"profit":false}]
Non-current Liabilities	-	-	45.41%	(32.18%)	33932.09%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":0.13,"profit":true},{"date":"2025-06-30","value":-0.09,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Total Liabilities	-	30.71%	(14.02%)	8.11%	134.93%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":22.76,"profit":true},{"date":"2025-03-31","value":-10.39,"profit":false},{"date":"2025-06-30","value":6.01,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Retained Earnings	-	15.71%	8.67%	12.41%	10.88%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":55.15,"profit":true},{"date":"2025-06-30","value":78.95,"profit":true},{"date":"2025-09-30","value":69.26,"profit":true}]
Other Stockholders' Equity	-	0.79%	0.78%	1.10%	1.16%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":68.1,"profit":true},{"date":"2025-03-31","value":67.53,"profit":true},{"date":"2025-06-30","value":94.88,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	-	(13.07%)	(9.01%)	(15.72%)	(18.03%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	(8.29%)	(9.79%)	(12.19%)	9.87%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-84.02,"profit":false},{"date":"2025-03-31","value":-99.12,"profit":false},{"date":"2025-06-30","value":-123.47,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	(65.65M)	(30.53M)	(119.67M)	[{"date":"2022-12-31","value":-6565200000,"profit":false},{"date":"2023-12-31","value":-3052900000,"profit":false},{"date":"2024-12-31","value":-11967400000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(2.20M)	(17.00K)	(30.55M)	[{"date":"2022-12-31","value":-219800000,"profit":false},{"date":"2023-12-31","value":-1700000,"profit":false},{"date":"2024-12-31","value":-3055200000,"profit":false}]

Financing Activities
Net Financing Cash Flow	59.39M	20.12M	412.96M	[{"date":"2022-12-31","value":14.38,"profit":true},{"date":"2023-12-31","value":4.87,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	(8.50M)	(10.35M)	262.89M	[{"date":"2022-12-31","value":-3.23,"profit":false},{"date":"2023-12-31","value":-3.94,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(67.85M)	(30.55M)	(119.81M)	[{"date":"2022-12-31","value":-6785000000,"profit":false},{"date":"2023-12-31","value":-3054600000,"profit":false},{"date":"2024-12-31","value":-11980500000,"profit":false}]

	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	-	(53.50%)	292.00%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-18.32,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(99.23%)	179617.65%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-0.06,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	(66.13%)	1952.88%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-3.39,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	-	21.79%	(2639.50%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-12114.33,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(54.98%)	292.21%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-18.82,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(31.06M)	(38.55M)	(37.05M)	(41.74M)	(41.13M)	[{"date":"2024-09-30","value":-3105900000,"profit":false},{"date":"2024-12-31","value":-3855400000,"profit":false},{"date":"2025-03-31","value":-3705100000,"profit":false},{"date":"2025-06-30","value":-4174300000,"profit":false},{"date":"2025-09-30","value":-4112500000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(26.76M)	(3.73M)	(86.27M)	(112.29M)	40.04M	[{"date":"2024-09-30","value":-66.83,"profit":false},{"date":"2024-12-31","value":-9.33,"profit":false},{"date":"2025-03-31","value":-215.45,"profit":false},{"date":"2025-06-30","value":-280.43,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	233.98M	1.85M	99.00K	1.72M	72.62M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":0.79,"profit":true},{"date":"2025-03-31","value":0.04,"profit":true},{"date":"2025-06-30","value":0.74,"profit":true},{"date":"2025-09-30","value":31.04,"profit":true}]

Net Change in Cash	176.11M	(40.30M)	(123.28M)	(152.55M)	71.56M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":-22.88,"profit":false},{"date":"2025-03-31","value":-70,"profit":false},{"date":"2025-06-30","value":-86.62,"profit":false},{"date":"2025-09-30","value":40.63,"profit":true}]

Free Cash Flow
Free Cash Flow	(31.06M)	(38.63M)	(37.07M)	(41.74M)	(46.13M)	[{"date":"2024-09-30","value":-3105900000,"profit":false},{"date":"2024-12-31","value":-3862800000,"profit":false},{"date":"2025-03-31","value":-3706900000,"profit":false},{"date":"2025-06-30","value":-4174300000,"profit":false},{"date":"2025-09-30","value":-4612500000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	24.13%	(3.90%)	12.66%	(1.48%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-16.15,"profit":false},{"date":"2025-06-30","value":52.48,"profit":true},{"date":"2025-09-30","value":-6.14,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(86.04%)	2209.88%	30.16%	(135.66%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-3.89,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":1.36,"profit":true},{"date":"2025-09-30","value":-6.14,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(99.21%)	(94.66%)	1639.39%	4116.96%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-2.41,"profit":false},{"date":"2025-03-31","value":-2.3,"profit":false},{"date":"2025-06-30","value":39.82,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Net Change in Cash	-	(122.88%)	205.94%	23.74%	(146.91%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-59.67,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":11.53,"profit":true},{"date":"2025-09-30","value":-71.34,"profit":false}]

Free Cash Flow
Free Cash Flow	-	24.37%	(4.04%)	12.61%	10.50%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-16.56,"profit":false},{"date":"2025-06-30","value":51.74,"profit":true},{"date":"2025-09-30","value":43.08,"profit":true}]

Zenas BioPharma, Inc. Common Stock Ratios

Zenas BioPharma, Inc. Common Stock Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	ZBIO
Cash Ratio	5.55
Current Ratio	5.66

Zenas BioPharma, Inc. Common Stock Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	ZBIO
ROA (LTM)	-33.72%
ROE (LTM)	-68.33%

Zenas BioPharma, Inc. Common Stock Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	ZBIO
Debt Ratio Lower is generally better. Negative is bad.	0.39
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.61

Zenas BioPharma, Inc. Common Stock Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	ZBIO
Trailing PE	2.61
Forward PE	NM
P/S (TTM)	95.80
P/B	7.32
Price/FCF	NM
EV/R	76.46
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Zenas BioPharma, Inc. Common Stock share price today?

Zenas BioPharma, Inc. Common Stock (ZBIO) share price today is $26.68

Can Indians buy Zenas BioPharma, Inc. Common Stock shares?

Yes, Indians can buy shares of Zenas BioPharma, Inc. Common Stock (ZBIO) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ZBIO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Zenas BioPharma, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Zenas BioPharma, Inc. Common Stock (ZBIO) via the Vested app. You can start investing in Zenas BioPharma, Inc. Common Stock (ZBIO) with a minimum investment of $1.

How to invest in Zenas BioPharma, Inc. Common Stock shares from India?

You can invest in shares of Zenas BioPharma, Inc. Common Stock (ZBIO) via Vested in three simple steps:

Click on Sign Up or Invest in ZBIO stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Zenas BioPharma, Inc. Common Stock shares

What is Zenas BioPharma, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Zenas BioPharma, Inc. Common Stock (ZBIO) is $44.6. The 52-week low price of Zenas BioPharma, Inc. Common Stock (ZBIO) is $6.11.

What is Zenas BioPharma, Inc. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Zenas BioPharma, Inc. Common Stock (ZBIO) is 2.6086

What is Zenas BioPharma, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Zenas BioPharma, Inc. Common Stock (ZBIO) is 7.32

What is Zenas BioPharma, Inc. Common Stock dividend yield?

The dividend yield of Zenas BioPharma, Inc. Common Stock (ZBIO) is 0.00%

What is the Market Cap of Zenas BioPharma, Inc. Common Stock?

The market capitalization of Zenas BioPharma, Inc. Common Stock (ZBIO) is $1.44B

What is Zenas BioPharma, Inc. Common Stock's stock symbol?

The stock symbol (or ticker) of Zenas BioPharma, Inc. Common Stock is ZBIO

How Can Investors Use Zenas BioPharma, Inc. Common Stock Share Price Data for Long-Term Investment Decisions?

Consider the share price of Zenas BioPharma, Inc. Common Stock as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Zenas BioPharma, Inc. Common Stock has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Zenas BioPharma, Inc. Common Stock shares for Indian investors?

When investing in Zenas BioPharma, Inc. Common Stock shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Zenas BioPharma, Inc. Common Stock stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Zenas BioPharma, Inc. Common Stock share price with other stocks in the same sector?

Rather than merely checking the share price of Zenas BioPharma, Inc. Common Stock and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Zenas BioPharma, Inc. Common Stock stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Zenas BioPharma, Inc. Common Stock Share Price

Zenas BioPharma, Inc. Common Stock Analyst Forecast

Zenas BioPharma, Inc. Common Stock Share Price Chart

Zenas BioPharma, Inc. Common Stock Key Stock Metrics

About Zenas BioPharma, Inc. Common Stock, Common Stock

Zenas BioPharma, Inc. Common Stock Stock Returns

Zenas BioPharma, Inc. Common Stock Financials

Zenas BioPharma, Inc. Common Stock Ratios

Zenas BioPharma, Inc. Common Stock Liquidity Ratios

Zenas BioPharma, Inc. Common Stock Asset Efficiency Ratios

Zenas BioPharma, Inc. Common Stock Liability Ratios

Zenas BioPharma, Inc. Common Stock Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Zenas BioPharma, Inc. Common Stock Share Price

Zenas BioPharma, Inc. Common Stock Analyst Forecast

Zenas BioPharma, Inc. Common Stock Share Price Chart

Zenas BioPharma, Inc. Common Stock Key Stock Metrics

About Zenas BioPharma, Inc. Common Stock, Common Stock

Zenas BioPharma, Inc. Common Stock Stock Returns

Zenas BioPharma, Inc. Common Stock Financials

Zenas BioPharma, Inc. Common Stock Ratios

Zenas BioPharma, Inc. Common Stock Liquidity Ratios

Zenas BioPharma, Inc. Common Stock Asset Efficiency Ratios

Zenas BioPharma, Inc. Common Stock Liability Ratios

Zenas BioPharma, Inc. Common Stock Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²